ANDA 216167, held by Zydus Pharms. Topiramate.
As of Nov 15, 2026, ANDA 216167 (Topiramate), held by Zydus Pharms, was first approved by FDA on Feb 9, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 9, 2023 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Topiramate200MG ยท capsule, extended release;oral | Topiramate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters